Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2020-05-27 | David K. Floyd Independent Director Age: 59 New Nominee: No prior service with the Company ...Mr. Floyd will be appointed to the Audit Committee and the ESG Committee. |
| 2021-04-30 | David K. Floyd Independent Director. Age: 60. Committees: Audit, ESG, Operating. Total Compensation: $216,000. |
| 2022-04-07 | DAVID K. FLOYD Independent Director Age: 61 Director Since: June 2020 Committees: ESG, Operating Other Public Boards: None Term Expires: 2023 |
| 2024-04-02 | David K. Floyd Independent Director Age: 63 Director Since: June 2020 Committees: Governance and Sustainability, Operating Other Public Boards: None Term Expires: 2026 Compensation: $275,985 |
| Filing Date | Source Excerpt |
|---|---|
| 2016-04-01 | David K. Floyd was nominated for election to the Board at the Board meeting held on March 22, 2016. Mr. Floyd, if elected, will replace Michael E. Werner who will be retiring effective as of the 2016 Annual Meeting. ... Mr. Floyd brings to the Board broad knowledge of the medical device industry, substantial executive leadership experience and extensive experience with strategy development, commercial operations, and mergers and acquisitions. ... The Governance Committee recently engaged a professional search firm to assist in identifying and evaluating candidates. Through such process, the Governance Committee identified David K. Floyd to be nominated for election to the Board. Mr. Floyd was nominated for election to the Board at the Board meeting held on March 22, 2016. Mr. Floyd, if elected, will replace Mr. Werner who will be retiring effective as of the 2016 Annual Meeting. |
| 2017-04-07 | David K. Floyd has been a member of the Board since 2016. Since 2012, Mr. Floyd has served as a Group President of Stryker Corporation, a leading global medical technology company. From 2007 to 2011, Mr. Floyd served as the U.S. President, and then Worldwide President, of Johnson & Johnson’s DePuy Orthopaedics. From 2005 to 2007, Mr. Floyd served as the General Manager, and then President, of the Spine Division of Abbott Laboratories. From 2004 to 2005, Mr. Floyd served as the President and Chief Executive Officer of AxioMed Spine Corporation, a medical device manufacturer. From 2000 to 2003, Mr. Floyd was the Vice President, U.S. Market, and then President, of Centerpulse Orthopedics Inc., a medical device manufacturer. Prior to that, Mr. Floyd held various leadership positions in sales, marketing and operations with OrthoLogic Corporation, Sulzer Orthopedics, Inc. and Zimmer, Inc., and has worked in the medical technology industry for over 28 years. Mr. Floyd was also a director of OrthoWorx, a business league founded to support the orthopedic industry, and served as its first Chief Executive Officer from 2011 to 2012. Mr. Floyd brings to the Board broad knowledge of the medical device industry, substantial executive leadership experience and extensive experience with strategy development, commercial operations, and mergers and acquisitions. |
| 2018-04-06 | David K. Floyd has been a member of the Board since 2016. Since 2012, Mr. Floyd has served as a Group President of Stryker Corporation, a leading global medical technology company. ... Mr. Floyd brings to the Board broad knowledge of the medical device industry, substantial executive leadership experience and extensive experience with strategy development, commercial operations, and mergers and acquisitions. ... Director Compensation Table For 2017: Mr. Floyd Fees Earned or Paid in Cash ($) 70,000, Stock Awards ($) 99,994, Total ($) 169,994. |
| 2019-04-08 | The following table provides summary information about each director nominee to be voted on at the Annual Meeting: David K. Floyd, 58, Director since 2016, Director Nominee, Committees: AC, CC, Independent: Yes. Director Compensation Table For 2018 shows Mr. Floyd received total compensation of $169,992. AC = Audit Committee; CC = Compensation Committee. |
| 2020-04-06 | David K. Floyd has been a member of the Board since 2016. David K. Floyd has been a member of the Board since 2016. From 2012 to June 2019, Mr. Floyd served as a Group President of Stryker Corporation, a leading global medical technology company. From 2007 to 2011, Mr. Floyd served as the U.S. President, and then Worldwide President, of Johnson & Johnson’s DePuy Orthopaedics. Prior thereto, Mr. Floyd has served in senior leadership positions with leading medical technology companies, including the Spine Division of Abbott Laboratories, OrthoLogic Corporation and Zimmer, Inc., and with several emerging medical device technology companies. Mr. Floyd was also a director of OrthoWorx, a business league founded to support the orthopedic industry, and served as its first Chief Executive Officer from 2011 to 2012. Mr. Floyd’s 32- year career as a leader in the life sciences industry, including serving as president and CEO of several leading medical technology companies, provides us deep and valuable insight into our life sciences business. His nearly 20 years of general management experience provides expertise on a broad range of company matters, including mergers and acquisitions, global business and operations and product commercialization. Mr. Floyd is also a National Association of Corporate Directors (NACD) Governance Fellow and serves as our Governance Committee Chairman. |
Data sourced from SEC filings. Last updated: 2026-02-03